nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0705	0.0952	CbGbCtD
Alprazolam—CYP3A7—Simvastatin—atherosclerosis	0.0705	0.0952	CbGbCtD
Alprazolam—CYP3A7—Lovastatin—atherosclerosis	0.069	0.0932	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.069	0.0932	CbGbCtD
Alprazolam—CYP3A5—Rosuvastatin—atherosclerosis	0.0569	0.0768	CbGbCtD
Alprazolam—CYP3A5—Simvastatin—atherosclerosis	0.0529	0.0714	CbGbCtD
Alprazolam—CYP3A5—Lovastatin—atherosclerosis	0.0517	0.0699	CbGbCtD
Alprazolam—CYP3A5—Pravastatin—atherosclerosis	0.0517	0.0699	CbGbCtD
Alprazolam—CYP2C9—Rosuvastatin—atherosclerosis	0.0381	0.0515	CbGbCtD
Alprazolam—CYP2C9—Simvastatin—atherosclerosis	0.0355	0.0479	CbGbCtD
Alprazolam—CYP2C9—Pravastatin—atherosclerosis	0.0347	0.0469	CbGbCtD
Alprazolam—CYP2C9—Lovastatin—atherosclerosis	0.0347	0.0469	CbGbCtD
Alprazolam—CYP3A4—Rosuvastatin—atherosclerosis	0.0222	0.03	CbGbCtD
Alprazolam—CYP3A4—Ezetimibe—atherosclerosis	0.0222	0.03	CbGbCtD
Alprazolam—CYP3A4—Simvastatin—atherosclerosis	0.0206	0.0279	CbGbCtD
Alprazolam—CYP3A4—Lovastatin—atherosclerosis	0.0202	0.0273	CbGbCtD
Alprazolam—CYP3A4—Pravastatin—atherosclerosis	0.0202	0.0273	CbGbCtD
Alprazolam—Sweating—Niacin—atherosclerosis	0.000621	0.00273	CcSEcCtD
Alprazolam—Chills—Lovastatin—atherosclerosis	0.000607	0.00268	CcSEcCtD
Alprazolam—Angiopathy—Ezetimibe—atherosclerosis	0.000602	0.00265	CcSEcCtD
Alprazolam—Erythema multiforme—Simvastatin—atherosclerosis	0.000598	0.00264	CcSEcCtD
Alprazolam—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000598	0.00264	CcSEcCtD
Alprazolam—Arthralgia—Rosuvastatin—atherosclerosis	0.000592	0.00261	CcSEcCtD
Alprazolam—Myalgia—Rosuvastatin—atherosclerosis	0.000592	0.00261	CcSEcCtD
Alprazolam—Mental disorder—Ezetimibe—atherosclerosis	0.000581	0.00256	CcSEcCtD
Alprazolam—Hepatitis—Niacin—atherosclerosis	0.000581	0.00256	CcSEcCtD
Alprazolam—Hypoaesthesia—Niacin—atherosclerosis	0.000578	0.00255	CcSEcCtD
Alprazolam—Malnutrition—Ezetimibe—atherosclerosis	0.000578	0.00255	CcSEcCtD
Alprazolam—Oedema peripheral—Niacin—atherosclerosis	0.000573	0.00252	CcSEcCtD
Alprazolam—Hepatitis—Pravastatin—atherosclerosis	0.000572	0.00252	CcSEcCtD
Alprazolam—Confusional state—Rosuvastatin—atherosclerosis	0.000572	0.00252	CcSEcCtD
Alprazolam—Back pain—Lovastatin—atherosclerosis	0.00057	0.00251	CcSEcCtD
Alprazolam—Hypoaesthesia—Pravastatin—atherosclerosis	0.000569	0.00251	CcSEcCtD
Alprazolam—Chills—Simvastatin—atherosclerosis	0.000568	0.0025	CcSEcCtD
Alprazolam—Muscle spasms—Lovastatin—atherosclerosis	0.000566	0.0025	CcSEcCtD
Alprazolam—Infection—Rosuvastatin—atherosclerosis	0.000564	0.00248	CcSEcCtD
Alprazolam—Back pain—Ezetimibe—atherosclerosis	0.000559	0.00246	CcSEcCtD
Alprazolam—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000556	0.00245	CcSEcCtD
Alprazolam—Muscle spasms—Ezetimibe—atherosclerosis	0.000555	0.00245	CcSEcCtD
Alprazolam—Vision blurred—Lovastatin—atherosclerosis	0.000555	0.00245	CcSEcCtD
Alprazolam—Mental disorder—Simvastatin—atherosclerosis	0.000555	0.00244	CcSEcCtD
Alprazolam—Tremor—Lovastatin—atherosclerosis	0.000552	0.00243	CcSEcCtD
Alprazolam—Ill-defined disorder—Lovastatin—atherosclerosis	0.000547	0.00241	CcSEcCtD
Alprazolam—Eye disorder—Niacin—atherosclerosis	0.000543	0.00239	CcSEcCtD
Alprazolam—Tinnitus—Niacin—atherosclerosis	0.000542	0.00239	CcSEcCtD
Alprazolam—Erythema multiforme—Pravastatin—atherosclerosis	0.000541	0.00238	CcSEcCtD
Alprazolam—Angioedema—Lovastatin—atherosclerosis	0.000538	0.00237	CcSEcCtD
Alprazolam—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000536	0.00236	CcSEcCtD
Alprazolam—Tinnitus—Pravastatin—atherosclerosis	0.000534	0.00235	CcSEcCtD
Alprazolam—Malaise—Lovastatin—atherosclerosis	0.000531	0.00234	CcSEcCtD
Alprazolam—Cardiac disorder—Pravastatin—atherosclerosis	0.000531	0.00234	CcSEcCtD
Alprazolam—Muscle spasms—Simvastatin—atherosclerosis	0.00053	0.00233	CcSEcCtD
Alprazolam—Vertigo—Lovastatin—atherosclerosis	0.000529	0.00233	CcSEcCtD
Alprazolam—Angioedema—Ezetimibe—atherosclerosis	0.000528	0.00233	CcSEcCtD
Alprazolam—Angiopathy—Niacin—atherosclerosis	0.000527	0.00232	CcSEcCtD
Alprazolam—Chills—Niacin—atherosclerosis	0.000521	0.0023	CcSEcCtD
Alprazolam—Malaise—Ezetimibe—atherosclerosis	0.000521	0.0023	CcSEcCtD
Alprazolam—Vision blurred—Simvastatin—atherosclerosis	0.000519	0.00229	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000517	0.00228	CcSEcCtD
Alprazolam—Tremor—Simvastatin—atherosclerosis	0.000516	0.00227	CcSEcCtD
Alprazolam—Chills—Pravastatin—atherosclerosis	0.000513	0.00226	CcSEcCtD
Alprazolam—Insomnia—Rosuvastatin—atherosclerosis	0.000513	0.00226	CcSEcCtD
Alprazolam—Ill-defined disorder—Simvastatin—atherosclerosis	0.000511	0.00225	CcSEcCtD
Alprazolam—Palpitations—Ezetimibe—atherosclerosis	0.000511	0.00225	CcSEcCtD
Alprazolam—Paraesthesia—Rosuvastatin—atherosclerosis	0.000509	0.00224	CcSEcCtD
Alprazolam—Malnutrition—Niacin—atherosclerosis	0.000506	0.00223	CcSEcCtD
Alprazolam—Angioedema—Simvastatin—atherosclerosis	0.000503	0.00222	CcSEcCtD
Alprazolam—Chest pain—Lovastatin—atherosclerosis	0.000502	0.00221	CcSEcCtD
Alprazolam—Arthralgia—Lovastatin—atherosclerosis	0.000502	0.00221	CcSEcCtD
Alprazolam—Myalgia—Lovastatin—atherosclerosis	0.000502	0.00221	CcSEcCtD
Alprazolam—Anxiety—Lovastatin—atherosclerosis	0.0005	0.0022	CcSEcCtD
Alprazolam—Dyspepsia—Rosuvastatin—atherosclerosis	0.000499	0.0022	CcSEcCtD
Alprazolam—Malaise—Simvastatin—atherosclerosis	0.000497	0.00219	CcSEcCtD
Alprazolam—Tension—Niacin—atherosclerosis	0.000496	0.00219	CcSEcCtD
Alprazolam—Discomfort—Lovastatin—atherosclerosis	0.000496	0.00218	CcSEcCtD
Alprazolam—Vertigo—Simvastatin—atherosclerosis	0.000495	0.00218	CcSEcCtD
Alprazolam—Chest pain—Ezetimibe—atherosclerosis	0.000492	0.00217	CcSEcCtD
Alprazolam—Myalgia—Ezetimibe—atherosclerosis	0.000492	0.00217	CcSEcCtD
Alprazolam—Arthralgia—Ezetimibe—atherosclerosis	0.000492	0.00217	CcSEcCtD
Alprazolam—Nervousness—Niacin—atherosclerosis	0.000491	0.00217	CcSEcCtD
Alprazolam—Dry mouth—Lovastatin—atherosclerosis	0.00049	0.00216	CcSEcCtD
Alprazolam—Tension—Pravastatin—atherosclerosis	0.000489	0.00215	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000489	0.00215	CcSEcCtD
Alprazolam—Muscle spasms—Niacin—atherosclerosis	0.000486	0.00214	CcSEcCtD
Alprazolam—Discomfort—Ezetimibe—atherosclerosis	0.000486	0.00214	CcSEcCtD
Alprazolam—Constipation—Rosuvastatin—atherosclerosis	0.000485	0.00214	CcSEcCtD
Alprazolam—Confusional state—Lovastatin—atherosclerosis	0.000485	0.00214	CcSEcCtD
Alprazolam—Nervousness—Pravastatin—atherosclerosis	0.000484	0.00213	CcSEcCtD
Alprazolam—Dry mouth—Ezetimibe—atherosclerosis	0.000481	0.00212	CcSEcCtD
Alprazolam—Muscle spasms—Pravastatin—atherosclerosis	0.000479	0.00211	CcSEcCtD
Alprazolam—Infection—Lovastatin—atherosclerosis	0.000478	0.0021	CcSEcCtD
Alprazolam—Vision blurred—Niacin—atherosclerosis	0.000477	0.0021	CcSEcCtD
Alprazolam—Confusional state—Ezetimibe—atherosclerosis	0.000475	0.00209	CcSEcCtD
Alprazolam—Vision blurred—Pravastatin—atherosclerosis	0.000469	0.00207	CcSEcCtD
Alprazolam—Arthralgia—Simvastatin—atherosclerosis	0.000469	0.00207	CcSEcCtD
Alprazolam—Chest pain—Simvastatin—atherosclerosis	0.000469	0.00207	CcSEcCtD
Alprazolam—Myalgia—Simvastatin—atherosclerosis	0.000469	0.00207	CcSEcCtD
Alprazolam—Infection—Ezetimibe—atherosclerosis	0.000468	0.00206	CcSEcCtD
Alprazolam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000467	0.00206	CcSEcCtD
Alprazolam—Anxiety—Simvastatin—atherosclerosis	0.000467	0.00206	CcSEcCtD
Alprazolam—Tremor—Pravastatin—atherosclerosis	0.000467	0.00206	CcSEcCtD
Alprazolam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000464	0.00204	CcSEcCtD
Alprazolam—Discomfort—Simvastatin—atherosclerosis	0.000463	0.00204	CcSEcCtD
Alprazolam—Nervous system disorder—Ezetimibe—atherosclerosis	0.000462	0.00204	CcSEcCtD
Alprazolam—Angioedema—Niacin—atherosclerosis	0.000462	0.00204	CcSEcCtD
Alprazolam—Ill-defined disorder—Pravastatin—atherosclerosis	0.000462	0.00204	CcSEcCtD
Alprazolam—Anorexia—Lovastatin—atherosclerosis	0.000458	0.00202	CcSEcCtD
Alprazolam—Skin disorder—Ezetimibe—atherosclerosis	0.000458	0.00202	CcSEcCtD
Alprazolam—Angioedema—Pravastatin—atherosclerosis	0.000455	0.00201	CcSEcCtD
Alprazolam—Vertigo—Niacin—atherosclerosis	0.000455	0.002	CcSEcCtD
Alprazolam—Syncope—Niacin—atherosclerosis	0.000454	0.002	CcSEcCtD
Alprazolam—Confusional state—Simvastatin—atherosclerosis	0.000453	0.002	CcSEcCtD
Alprazolam—Urticaria—Rosuvastatin—atherosclerosis	0.000451	0.00199	CcSEcCtD
Alprazolam—Oedema—Simvastatin—atherosclerosis	0.00045	0.00198	CcSEcCtD
Alprazolam—Malaise—Pravastatin—atherosclerosis	0.000449	0.00198	CcSEcCtD
Alprazolam—Abdominal pain—Rosuvastatin—atherosclerosis	0.000448	0.00198	CcSEcCtD
Alprazolam—Vertigo—Pravastatin—atherosclerosis	0.000448	0.00197	CcSEcCtD
Alprazolam—Palpitations—Niacin—atherosclerosis	0.000447	0.00197	CcSEcCtD
Alprazolam—Infection—Simvastatin—atherosclerosis	0.000447	0.00197	CcSEcCtD
Alprazolam—Loss of consciousness—Niacin—atherosclerosis	0.000445	0.00196	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000438	0.00193	CcSEcCtD
Alprazolam—Insomnia—Lovastatin—atherosclerosis	0.000435	0.00192	CcSEcCtD
Alprazolam—Paraesthesia—Lovastatin—atherosclerosis	0.000432	0.0019	CcSEcCtD
Alprazolam—Arthralgia—Niacin—atherosclerosis	0.000431	0.0019	CcSEcCtD
Alprazolam—Myalgia—Niacin—atherosclerosis	0.000431	0.0019	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00043	0.00189	CcSEcCtD
Alprazolam—Anorexia—Simvastatin—atherosclerosis	0.000429	0.00189	CcSEcCtD
Alprazolam—Dyspnoea—Lovastatin—atherosclerosis	0.000429	0.00189	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000428	0.00188	CcSEcCtD
Alprazolam—Insomnia—Ezetimibe—atherosclerosis	0.000426	0.00188	CcSEcCtD
Alprazolam—Chest pain—Pravastatin—atherosclerosis	0.000424	0.00187	CcSEcCtD
Alprazolam—Myalgia—Pravastatin—atherosclerosis	0.000424	0.00187	CcSEcCtD
Alprazolam—Arthralgia—Pravastatin—atherosclerosis	0.000424	0.00187	CcSEcCtD
Alprazolam—Paraesthesia—Ezetimibe—atherosclerosis	0.000423	0.00187	CcSEcCtD
Alprazolam—Dyspepsia—Lovastatin—atherosclerosis	0.000423	0.00186	CcSEcCtD
Alprazolam—Anxiety—Pravastatin—atherosclerosis	0.000423	0.00186	CcSEcCtD
Alprazolam—Dry mouth—Niacin—atherosclerosis	0.000421	0.00186	CcSEcCtD
Alprazolam—Dyspnoea—Ezetimibe—atherosclerosis	0.00042	0.00185	CcSEcCtD
Alprazolam—Discomfort—Pravastatin—atherosclerosis	0.000419	0.00185	CcSEcCtD
Alprazolam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000418	0.00184	CcSEcCtD
Alprazolam—Decreased appetite—Lovastatin—atherosclerosis	0.000418	0.00184	CcSEcCtD
Alprazolam—Dyspepsia—Ezetimibe—atherosclerosis	0.000415	0.00183	CcSEcCtD
Alprazolam—Fatigue—Lovastatin—atherosclerosis	0.000414	0.00183	CcSEcCtD
Alprazolam—Oedema—Niacin—atherosclerosis	0.000413	0.00182	CcSEcCtD
Alprazolam—Constipation—Lovastatin—atherosclerosis	0.000411	0.00181	CcSEcCtD
Alprazolam—Confusional state—Pravastatin—atherosclerosis	0.00041	0.00181	CcSEcCtD
Alprazolam—Decreased appetite—Ezetimibe—atherosclerosis	0.00041	0.00181	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00041	0.00181	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000407	0.00179	CcSEcCtD
Alprazolam—Asthenia—Rosuvastatin—atherosclerosis	0.000407	0.00179	CcSEcCtD
Alprazolam—Insomnia—Simvastatin—atherosclerosis	0.000407	0.00179	CcSEcCtD
Alprazolam—Oedema—Pravastatin—atherosclerosis	0.000407	0.00179	CcSEcCtD
Alprazolam—Fatigue—Ezetimibe—atherosclerosis	0.000407	0.00179	CcSEcCtD
Alprazolam—Shock—Niacin—atherosclerosis	0.000406	0.00179	CcSEcCtD
Alprazolam—Infection—Pravastatin—atherosclerosis	0.000404	0.00178	CcSEcCtD
Alprazolam—Paraesthesia—Simvastatin—atherosclerosis	0.000404	0.00178	CcSEcCtD
Alprazolam—Constipation—Ezetimibe—atherosclerosis	0.000403	0.00178	CcSEcCtD
Alprazolam—Tachycardia—Niacin—atherosclerosis	0.000403	0.00178	CcSEcCtD
Alprazolam—Pruritus—Rosuvastatin—atherosclerosis	0.000401	0.00177	CcSEcCtD
Alprazolam—Skin disorder—Niacin—atherosclerosis	0.000401	0.00177	CcSEcCtD
Alprazolam—Dyspnoea—Simvastatin—atherosclerosis	0.000401	0.00177	CcSEcCtD
Alprazolam—Hyperhidrosis—Niacin—atherosclerosis	0.000399	0.00176	CcSEcCtD
Alprazolam—Feeling abnormal—Lovastatin—atherosclerosis	0.000396	0.00175	CcSEcCtD
Alprazolam—Dyspepsia—Simvastatin—atherosclerosis	0.000396	0.00174	CcSEcCtD
Alprazolam—Anorexia—Niacin—atherosclerosis	0.000394	0.00173	CcSEcCtD
Alprazolam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000393	0.00173	CcSEcCtD
Alprazolam—Hyperhidrosis—Pravastatin—atherosclerosis	0.000393	0.00173	CcSEcCtD
Alprazolam—Decreased appetite—Simvastatin—atherosclerosis	0.000391	0.00172	CcSEcCtD
Alprazolam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000389	0.00171	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000388	0.00171	CcSEcCtD
Alprazolam—Diarrhoea—Rosuvastatin—atherosclerosis	0.000388	0.00171	CcSEcCtD
Alprazolam—Fatigue—Simvastatin—atherosclerosis	0.000388	0.00171	CcSEcCtD
Alprazolam—Anorexia—Pravastatin—atherosclerosis	0.000388	0.00171	CcSEcCtD
Alprazolam—Hypotension—Niacin—atherosclerosis	0.000386	0.0017	CcSEcCtD
Alprazolam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000386	0.0017	CcSEcCtD
Alprazolam—Constipation—Simvastatin—atherosclerosis	0.000385	0.00169	CcSEcCtD
Alprazolam—Urticaria—Lovastatin—atherosclerosis	0.000382	0.00168	CcSEcCtD
Alprazolam—Abdominal pain—Lovastatin—atherosclerosis	0.00038	0.00167	CcSEcCtD
Alprazolam—Body temperature increased—Lovastatin—atherosclerosis	0.00038	0.00167	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000376	0.00166	CcSEcCtD
Alprazolam—Dizziness—Rosuvastatin—atherosclerosis	0.000375	0.00165	CcSEcCtD
Alprazolam—Urticaria—Ezetimibe—atherosclerosis	0.000375	0.00165	CcSEcCtD
Alprazolam—Insomnia—Niacin—atherosclerosis	0.000373	0.00165	CcSEcCtD
Alprazolam—Abdominal pain—Ezetimibe—atherosclerosis	0.000373	0.00164	CcSEcCtD
Alprazolam—Body temperature increased—Ezetimibe—atherosclerosis	0.000373	0.00164	CcSEcCtD
Alprazolam—Paraesthesia—Niacin—atherosclerosis	0.000371	0.00163	CcSEcCtD
Alprazolam—Feeling abnormal—Simvastatin—atherosclerosis	0.000371	0.00163	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00037	0.00163	CcSEcCtD
Alprazolam—Dyspnoea—Niacin—atherosclerosis	0.000368	0.00162	CcSEcCtD
Alprazolam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000368	0.00162	CcSEcCtD
Alprazolam—Insomnia—Pravastatin—atherosclerosis	0.000368	0.00162	CcSEcCtD
Alprazolam—Somnolence—Niacin—atherosclerosis	0.000367	0.00162	CcSEcCtD
Alprazolam—Paraesthesia—Pravastatin—atherosclerosis	0.000365	0.00161	CcSEcCtD
Alprazolam—Dyspepsia—Niacin—atherosclerosis	0.000363	0.0016	CcSEcCtD
Alprazolam—Dyspnoea—Pravastatin—atherosclerosis	0.000362	0.0016	CcSEcCtD
Alprazolam—Decreased appetite—Niacin—atherosclerosis	0.000359	0.00158	CcSEcCtD
Alprazolam—Dyspepsia—Pravastatin—atherosclerosis	0.000358	0.00158	CcSEcCtD
Alprazolam—Rash—Rosuvastatin—atherosclerosis	0.000358	0.00158	CcSEcCtD
Alprazolam—Dermatitis—Rosuvastatin—atherosclerosis	0.000357	0.00157	CcSEcCtD
Alprazolam—Urticaria—Simvastatin—atherosclerosis	0.000357	0.00157	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Niacin—atherosclerosis	0.000356	0.00157	CcSEcCtD
Alprazolam—Abdominal pain—Simvastatin—atherosclerosis	0.000355	0.00157	CcSEcCtD
Alprazolam—Body temperature increased—Simvastatin—atherosclerosis	0.000355	0.00157	CcSEcCtD
Alprazolam—Headache—Rosuvastatin—atherosclerosis	0.000355	0.00157	CcSEcCtD
Alprazolam—Hypersensitivity—Lovastatin—atherosclerosis	0.000354	0.00156	CcSEcCtD
Alprazolam—Decreased appetite—Pravastatin—atherosclerosis	0.000353	0.00156	CcSEcCtD
Alprazolam—Fatigue—Pravastatin—atherosclerosis	0.000351	0.00154	CcSEcCtD
Alprazolam—Constipation—Pravastatin—atherosclerosis	0.000348	0.00153	CcSEcCtD
Alprazolam—Hypersensitivity—Ezetimibe—atherosclerosis	0.000347	0.00153	CcSEcCtD
Alprazolam—Asthenia—Lovastatin—atherosclerosis	0.000345	0.00152	CcSEcCtD
Alprazolam—Pruritus—Lovastatin—atherosclerosis	0.00034	0.0015	CcSEcCtD
Alprazolam—Asthenia—Ezetimibe—atherosclerosis	0.000338	0.00149	CcSEcCtD
Alprazolam—Gastrointestinal pain—Niacin—atherosclerosis	0.000338	0.00149	CcSEcCtD
Alprazolam—Nausea—Rosuvastatin—atherosclerosis	0.000337	0.00148	CcSEcCtD
Alprazolam—Feeling abnormal—Pravastatin—atherosclerosis	0.000335	0.00148	CcSEcCtD
Alprazolam—Pruritus—Ezetimibe—atherosclerosis	0.000334	0.00147	CcSEcCtD
Alprazolam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000332	0.00146	CcSEcCtD
Alprazolam—Hypersensitivity—Simvastatin—atherosclerosis	0.000331	0.00146	CcSEcCtD
Alprazolam—Diarrhoea—Lovastatin—atherosclerosis	0.000329	0.00145	CcSEcCtD
Alprazolam—Urticaria—Niacin—atherosclerosis	0.000328	0.00145	CcSEcCtD
Alprazolam—Abdominal pain—Niacin—atherosclerosis	0.000326	0.00144	CcSEcCtD
Alprazolam—Body temperature increased—Niacin—atherosclerosis	0.000326	0.00144	CcSEcCtD
Alprazolam—Urticaria—Pravastatin—atherosclerosis	0.000323	0.00142	CcSEcCtD
Alprazolam—Asthenia—Simvastatin—atherosclerosis	0.000323	0.00142	CcSEcCtD
Alprazolam—Diarrhoea—Ezetimibe—atherosclerosis	0.000323	0.00142	CcSEcCtD
Alprazolam—Body temperature increased—Pravastatin—atherosclerosis	0.000321	0.00142	CcSEcCtD
Alprazolam—Abdominal pain—Pravastatin—atherosclerosis	0.000321	0.00142	CcSEcCtD
Alprazolam—Pruritus—Simvastatin—atherosclerosis	0.000318	0.0014	CcSEcCtD
Alprazolam—Dizziness—Lovastatin—atherosclerosis	0.000318	0.0014	CcSEcCtD
Alprazolam—Dizziness—Ezetimibe—atherosclerosis	0.000312	0.00137	CcSEcCtD
Alprazolam—Diarrhoea—Simvastatin—atherosclerosis	0.000308	0.00136	CcSEcCtD
Alprazolam—Vomiting—Lovastatin—atherosclerosis	0.000306	0.00135	CcSEcCtD
Alprazolam—Hypersensitivity—Niacin—atherosclerosis	0.000304	0.00134	CcSEcCtD
Alprazolam—Rash—Lovastatin—atherosclerosis	0.000303	0.00134	CcSEcCtD
Alprazolam—Dermatitis—Lovastatin—atherosclerosis	0.000303	0.00133	CcSEcCtD
Alprazolam—Headache—Lovastatin—atherosclerosis	0.000301	0.00133	CcSEcCtD
Alprazolam—Vomiting—Ezetimibe—atherosclerosis	0.0003	0.00132	CcSEcCtD
Alprazolam—Hypersensitivity—Pravastatin—atherosclerosis	0.0003	0.00132	CcSEcCtD
Alprazolam—Dizziness—Simvastatin—atherosclerosis	0.000297	0.00131	CcSEcCtD
Alprazolam—Rash—Ezetimibe—atherosclerosis	0.000297	0.00131	CcSEcCtD
Alprazolam—Dermatitis—Ezetimibe—atherosclerosis	0.000297	0.00131	CcSEcCtD
Alprazolam—Asthenia—Niacin—atherosclerosis	0.000296	0.00131	CcSEcCtD
Alprazolam—Headache—Ezetimibe—atherosclerosis	0.000295	0.0013	CcSEcCtD
Alprazolam—Pruritus—Niacin—atherosclerosis	0.000292	0.00129	CcSEcCtD
Alprazolam—Asthenia—Pravastatin—atherosclerosis	0.000292	0.00129	CcSEcCtD
Alprazolam—Pruritus—Pravastatin—atherosclerosis	0.000288	0.00127	CcSEcCtD
Alprazolam—Vomiting—Simvastatin—atherosclerosis	0.000286	0.00126	CcSEcCtD
Alprazolam—Nausea—Lovastatin—atherosclerosis	0.000286	0.00126	CcSEcCtD
Alprazolam—Rash—Simvastatin—atherosclerosis	0.000284	0.00125	CcSEcCtD
Alprazolam—Dermatitis—Simvastatin—atherosclerosis	0.000283	0.00125	CcSEcCtD
Alprazolam—Diarrhoea—Niacin—atherosclerosis	0.000283	0.00124	CcSEcCtD
Alprazolam—Headache—Simvastatin—atherosclerosis	0.000282	0.00124	CcSEcCtD
Alprazolam—Nausea—Ezetimibe—atherosclerosis	0.00028	0.00123	CcSEcCtD
Alprazolam—Diarrhoea—Pravastatin—atherosclerosis	0.000278	0.00123	CcSEcCtD
Alprazolam—Dizziness—Niacin—atherosclerosis	0.000273	0.0012	CcSEcCtD
Alprazolam—Dizziness—Pravastatin—atherosclerosis	0.000269	0.00118	CcSEcCtD
Alprazolam—Nausea—Simvastatin—atherosclerosis	0.000267	0.00118	CcSEcCtD
Alprazolam—Vomiting—Niacin—atherosclerosis	0.000263	0.00116	CcSEcCtD
Alprazolam—Rash—Niacin—atherosclerosis	0.00026	0.00115	CcSEcCtD
Alprazolam—Dermatitis—Niacin—atherosclerosis	0.00026	0.00115	CcSEcCtD
Alprazolam—Headache—Niacin—atherosclerosis	0.000259	0.00114	CcSEcCtD
Alprazolam—Vomiting—Pravastatin—atherosclerosis	0.000258	0.00114	CcSEcCtD
Alprazolam—Rash—Pravastatin—atherosclerosis	0.000256	0.00113	CcSEcCtD
Alprazolam—Dermatitis—Pravastatin—atherosclerosis	0.000256	0.00113	CcSEcCtD
Alprazolam—Headache—Pravastatin—atherosclerosis	0.000255	0.00112	CcSEcCtD
Alprazolam—Nausea—Niacin—atherosclerosis	0.000245	0.00108	CcSEcCtD
Alprazolam—Nausea—Pravastatin—atherosclerosis	0.000241	0.00106	CcSEcCtD
Alprazolam—Loxapine—HRH1—atherosclerosis	6e-05	0.486	CrCbGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.96e-05	0.000906	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.93e-05	0.000899	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—APOB—atherosclerosis	2.93e-05	0.000898	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.9e-05	0.000889	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLTP—atherosclerosis	2.9e-05	0.000888	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—APOB—atherosclerosis	2.88e-05	0.000882	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—APOB—atherosclerosis	2.86e-05	0.000877	CbGpPWpGaD
Alprazolam—Ketazolam—ALB—atherosclerosis	2.86e-05	0.231	CrCbGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	2.85e-05	0.000874	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	2.81e-05	0.000861	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.78e-05	0.000851	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCG1—atherosclerosis	2.75e-05	0.000842	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	2.69e-05	0.000825	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.64e-05	0.000808	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.59e-05	0.000794	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—FABP4—atherosclerosis	2.59e-05	0.000792	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LCAT—atherosclerosis	2.59e-05	0.000792	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.57e-05	0.000786	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA4—atherosclerosis	2.54e-05	0.000777	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.52e-05	0.000771	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LTA4H—atherosclerosis	2.52e-05	0.00077	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCG8—atherosclerosis	2.52e-05	0.00077	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.5e-05	0.000766	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.5e-05	0.000766	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.5e-05	0.000766	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.5e-05	0.000766	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP7A1—atherosclerosis	2.49e-05	0.000764	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—AKT1—atherosclerosis	2.49e-05	0.000763	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.47e-05	0.000757	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2.47e-05	0.000756	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.46e-05	0.000753	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.43e-05	0.000745	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.43e-05	0.000744	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.41e-05	0.000739	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.39e-05	0.00073	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.37e-05	0.000726	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.36e-05	0.000724	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.32e-05	0.00071	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP27A1—atherosclerosis	2.3e-05	0.000706	CbGpPWpGaD
Alprazolam—Clonazepam—ALB—atherosclerosis	2.3e-05	0.187	CrCbGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.29e-05	0.0007	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.28e-05	0.000698	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.27e-05	0.000694	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.22e-05	0.000681	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.2e-05	0.000674	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALOX5AP—atherosclerosis	2.19e-05	0.000669	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALOX15—atherosclerosis	2.19e-05	0.000669	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLA2G2A—atherosclerosis	2.19e-05	0.000669	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA2—atherosclerosis	2.19e-05	0.000669	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	2.17e-05	0.000666	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.17e-05	0.000666	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCG5—atherosclerosis	2.16e-05	0.000661	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.13e-05	0.000651	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LPA—atherosclerosis	2.08e-05	0.000638	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.07e-05	0.000635	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLTP—atherosclerosis	2.04e-05	0.000626	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.02e-05	0.00062	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—BGN—atherosclerosis	2.02e-05	0.000618	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA5—atherosclerosis	2e-05	0.000612	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2e-05	0.000611	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCG1—atherosclerosis	1.99e-05	0.000609	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.94e-05	0.000595	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.93e-05	0.00059	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000589	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.89e-05	0.00058	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.88e-05	0.000577	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	1.87e-05	0.000573	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.87e-05	0.000573	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—FABP4—atherosclerosis	1.87e-05	0.000572	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LCAT—atherosclerosis	1.87e-05	0.000572	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALOX5—atherosclerosis	1.86e-05	0.000569	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.84e-05	0.000563	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA4—atherosclerosis	1.83e-05	0.000562	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.83e-05	0.00056	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.81e-05	0.000553	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP7A1—atherosclerosis	1.8e-05	0.000552	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.79e-05	0.00055	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.77e-05	0.000543	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.77e-05	0.000543	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.76e-05	0.00054	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.75e-05	0.000536	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NAMPT—atherosclerosis	1.67e-05	0.00051	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP27A1—atherosclerosis	1.67e-05	0.00051	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LIPC—atherosclerosis	1.66e-05	0.000507	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.65e-05	0.000506	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOC3—atherosclerosis	1.65e-05	0.000504	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LDLR—atherosclerosis	1.64e-05	0.000501	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CETP—atherosclerosis	1.6e-05	0.000489	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.58e-05	0.000484	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA2—atherosclerosis	1.58e-05	0.000484	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.58e-05	0.000484	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.58e-05	0.000484	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.56e-05	0.000478	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.54e-05	0.000472	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SCARB1—atherosclerosis	1.53e-05	0.000469	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPA—atherosclerosis	1.51e-05	0.000461	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.47e-05	0.000451	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—BGN—atherosclerosis	1.46e-05	0.000447	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000442	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA5—atherosclerosis	1.44e-05	0.000442	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.43e-05	0.000439	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.4e-05	0.000429	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.39e-05	0.000426	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLTP—atherosclerosis	1.35e-05	0.000413	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.34e-05	0.000411	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—FABP4—atherosclerosis	1.32e-05	0.000404	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LCAT—atherosclerosis	1.32e-05	0.000404	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA4—atherosclerosis	1.29e-05	0.000396	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000394	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.27e-05	0.000389	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.21e-05	0.000371	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.2e-05	0.000369	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LIPC—atherosclerosis	1.2e-05	0.000367	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOC3—atherosclerosis	1.19e-05	0.000364	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LDLR—atherosclerosis	1.18e-05	0.000362	CbGpPWpGaD
Alprazolam—Diazepam—ALB—atherosclerosis	1.18e-05	0.0955	CrCbGaD
Alprazolam—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.17e-05	0.00036	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.17e-05	0.000358	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.17e-05	0.000358	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.16e-05	0.000354	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CETP—atherosclerosis	1.15e-05	0.000354	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.13e-05	0.000345	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.11e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.11e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA2—atherosclerosis	1.11e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.11e-05	0.000341	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.11e-05	0.000339	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000338	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.1e-05	0.000337	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.1e-05	0.000336	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPA—atherosclerosis	1.06e-05	0.000325	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOB—atherosclerosis	1.06e-05	0.000324	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.04e-05	0.00032	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000315	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—BGN—atherosclerosis	1.03e-05	0.000315	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.02e-05	0.000313	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA5—atherosclerosis	1.02e-05	0.000312	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LPL—atherosclerosis	1.01e-05	0.000309	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.89e-06	0.000303	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GPX1—atherosclerosis	9.86e-06	0.000302	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	9.8e-06	0.0003	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.69e-06	0.000297	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.6e-06	0.000294	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CD36—atherosclerosis	9.6e-06	0.000294	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.58e-06	0.000293	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.47e-06	0.00029	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.31e-06	0.000285	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.24e-06	0.000283	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—atherosclerosis	9.1e-06	0.000279	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARA—atherosclerosis	8.93e-06	0.000273	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.75e-06	0.000268	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LCAT—atherosclerosis	8.69e-06	0.000266	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—FABP4—atherosclerosis	8.69e-06	0.000266	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AGT—atherosclerosis	8.64e-06	0.000265	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA4—atherosclerosis	8.53e-06	0.000261	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.49e-06	0.00026	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOE—atherosclerosis	8.47e-06	0.000259	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.44e-06	0.000259	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LIPC—atherosclerosis	8.44e-06	0.000258	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAV1—atherosclerosis	8.39e-06	0.000257	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOC3—atherosclerosis	8.39e-06	0.000257	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.38e-06	0.000257	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA1—atherosclerosis	8.37e-06	0.000256	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LDLR—atherosclerosis	8.33e-06	0.000255	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CETP—atherosclerosis	8.14e-06	0.000249	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.99e-06	0.000245	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.8e-06	0.000239	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.75e-06	0.000237	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOB—atherosclerosis	7.65e-06	0.000234	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.64e-06	0.000234	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.59e-06	0.000232	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.44e-06	0.000228	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARG—atherosclerosis	7.38e-06	0.000226	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.36e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.34e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.34e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.34e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA2—atherosclerosis	7.34e-06	0.000225	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPL—atherosclerosis	7.3e-06	0.000224	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.25e-06	0.000222	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—INS—atherosclerosis	7.24e-06	0.000222	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GPX1—atherosclerosis	7.13e-06	0.000218	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPA—atherosclerosis	7.01e-06	0.000215	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CD36—atherosclerosis	6.94e-06	0.000213	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—BGN—atherosclerosis	6.78e-06	0.000208	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA5—atherosclerosis	6.72e-06	0.000206	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.64e-06	0.000203	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—atherosclerosis	6.63e-06	0.000203	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.58e-06	0.000201	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.56e-06	0.000201	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.46e-06	0.000198	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARA—atherosclerosis	6.45e-06	0.000198	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NOS3—atherosclerosis	6.35e-06	0.000194	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AGT—atherosclerosis	6.25e-06	0.000191	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.24e-06	0.000191	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOE—atherosclerosis	6.12e-06	0.000188	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAV1—atherosclerosis	6.07e-06	0.000186	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA1—atherosclerosis	6.05e-06	0.000185	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.8e-06	0.000178	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.63e-06	0.000172	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.6e-06	0.000171	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LIPC—atherosclerosis	5.56e-06	0.00017	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOC3—atherosclerosis	5.53e-06	0.000169	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.53e-06	0.000169	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LDLR—atherosclerosis	5.5e-06	0.000168	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOB—atherosclerosis	5.39e-06	0.000165	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CETP—atherosclerosis	5.37e-06	0.000164	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARG—atherosclerosis	5.33e-06	0.000163	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.25e-06	0.000161	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—INS—atherosclerosis	5.23e-06	0.00016	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPL—atherosclerosis	5.15e-06	0.000158	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.14e-06	0.000157	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GPX1—atherosclerosis	5.02e-06	0.000154	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CD36—atherosclerosis	4.89e-06	0.00015	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.86e-06	0.000149	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—atherosclerosis	4.8e-06	0.000147	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.64e-06	0.000142	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NOS3—atherosclerosis	4.59e-06	0.00014	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARA—atherosclerosis	4.55e-06	0.000139	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AGT—atherosclerosis	4.41e-06	0.000135	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.33e-06	0.000133	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOE—atherosclerosis	4.32e-06	0.000132	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAV1—atherosclerosis	4.28e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA1—atherosclerosis	4.27e-06	0.000131	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.2e-06	0.000128	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.9e-06	0.000119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARG—atherosclerosis	3.76e-06	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.71e-06	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—INS—atherosclerosis	3.69e-06	0.000113	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOB—atherosclerosis	3.56e-06	0.000109	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.46e-06	0.000106	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPL—atherosclerosis	3.4e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—atherosclerosis	3.38e-06	0.000104	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GPX1—atherosclerosis	3.31e-06	0.000101	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NOS3—atherosclerosis	3.23e-06	9.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CD36—atherosclerosis	3.23e-06	9.88e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.06e-06	9.36e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARA—atherosclerosis	3e-06	9.19e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.96e-06	9.06e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—atherosclerosis	2.92e-06	8.93e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AGT—atherosclerosis	2.91e-06	8.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOE—atherosclerosis	2.85e-06	8.72e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAV1—atherosclerosis	2.82e-06	8.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA1—atherosclerosis	2.81e-06	8.62e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.57e-06	7.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARG—atherosclerosis	2.48e-06	7.59e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—INS—atherosclerosis	2.43e-06	7.45e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—atherosclerosis	2.23e-06	6.83e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NOS3—atherosclerosis	2.13e-06	6.53e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—atherosclerosis	2.11e-06	6.46e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.95e-06	5.97e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—atherosclerosis	1.49e-06	4.55e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—atherosclerosis	9.8e-07	3e-05	CbGpPWpGaD
